COM:ADAPTIVEBIOTECH
Adaptive Biotechnologies
- Stock
Last Close
4.37
22/11 21:00
Market Cap
515.79M
Beta: -
Volume Today
2.30M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 6.32M - | 8.45M 33.86% | 11.57M 36.82% | 16.66M 44.07% | 16.86M 1.17% | 14.45M 14.28% | ||
average payables | 1.88M - | 3.12M 66.25% | 3.85M 23.12% | 3.27M 14.90% | 5.70M 74.07% | 7.90M 38.73% | ||
average receivables | 5.19M - | 8.74M 68.28% | 11.36M 29.97% | 13.73M 20.83% | 28.73M 109.30% | 39.01M 35.78% | ||
book value per share | -2.13 - | -2.45 14.91% | 8.26 437.25% | 5.66 31.39% | 4.30 24.03% | 3.26 24.32% | 2.14 34.44% | |
capex per share | -0.02 - | -0.06 152.11% | -0.16 170.23% | -0.14 11.51% | -0.44 207.00% | -0.11 73.92% | ||
capex to depreciation | -0.43 - | -1.05 143.54% | -1.44 36.52% | -2.22 54.39% | -4.43 99.39% | -0.78 82.34% | ||
capex to operating cash flow | 0.07 - | 0.20 172.43% | -0.05 127.84% | 0.13 330.38% | 0.32 155.04% | 0.09 72.26% | ||
capex to revenue | -0.07 - | -0.11 74.14% | -0.13 15.99% | -0.19 45.17% | -0.40 109.32% | -0.09 77.95% | ||
cash per share | 1.82 - | 1.57 14.12% | 8.34 432.89% | 5.25 37.11% | 2.52 52.04% | 3.50 38.97% | 2.40 31.37% | |
days of inventory on hand | 111.55 - | 145.46 30.40% | 148.61 2.17% | 227.83 53.30% | 142.61 37.40% | 91.10 36.12% | 68.26 25.06% | |
days payables outstanding | 45.72 - | 33.27 27.22% | 72.97 119.30% | 52.44 28.13% | 24.48 53.31% | 50.95 108.11% | 36.47 28.42% | |
days sales outstanding | 52.99 - | 31.52 40.52% | 54.39 72.54% | 37.27 31.46% | 41.17 10.45% | 78.90 91.65% | 81.39 3.16% | |
debt to assets | 0.04 - | 0.10 140.78% | 0.12 25.26% | 0.13 4.18% | 0.01 88.74% | |||
debt to equity | 0.06 - | 0.15 126.37% | 0.19 27.48% | 0.23 25.77% | 0.03 86.92% | |||
dividend yield | ||||||||
earnings yield | -0.01 - | -0.01 8.44% | -0.03 160.02% | -0.02 36.68% | -0.05 190.09% | -0.13 150.62% | -0.32 143.33% | |
enterprise value | 4.16B - | 4.19B 0.73% | 2.01B 52.09% | 7.74B 285.34% | 3.91B 49.49% | 1.11B 71.70% | 741.19M 33.03% | |
enterprise value over ebitda | -112.53 - | -95.85 14.83% | -26.20 72.66% | -51.24 95.57% | -18.87 63.18% | -5.69 69.83% | -4.13 27.41% | |
ev to operating cash flow | -119.45 - | -130.01 8.84% | 9.78 107.52% | -51.73 628.79% | -20.29 60.77% | -6.02 70.35% | 16.67 377.05% | |
ev to sales | 108.29 - | 75.35 30.42% | 23.62 68.65% | 78.71 233.20% | 25.34 67.80% | 5.97 76.43% | 4.35 27.12% | |
free cash flow per share | -0.35 - | -0.37 3.25% | 2.81 867.40% | -1.28 145.73% | -1.81 41.20% | -1.41 22.48% | 0.31 121.91% | |
free cash flow yield | -0.01 - | -0.01 3.25% | 0.09 1,133.63% | -0.02 123.14% | -0.06 197.55% | -0.18 184.70% | 0.06 134.16% | |
graham net net | -3.68 - | -3.97 7.69% | 3.61 190.98% | 2.51 30.39% | 0.40 83.98% | 1.00 149.13% | 0.20 79.81% | |
graham number | 4.41 - | 4.93 11.63% | 12.57 155.16% | 11.65 7.34% | 11.91 2.27% | 8.56 28.14% | 8.66 1.15% | |
income quality | 0.81 - | 0.69 14.66% | -2.99 531.08% | 1.02 134.19% | 0.93 9.18% | 0.92 1.26% | -0.20 121.50% | |
intangibles to total assets | 0.37 - | 0.40 7.58% | 0.14 64.00% | 0.12 19.35% | 0.14 19.32% | 0.15 6.35% | 0.18 22.54% | |
interest coverage | -47.24 - | -14.61 69.07% | ||||||
interest debt per share | 0.53 - | 0.82 55.31% | 0.80 3.15% | 0.79 1.08% | 0.16 79.61% | |||
inventory turnover | 3.27 - | 2.51 23.31% | 2.46 2.12% | 1.60 34.77% | 2.56 59.75% | 4.01 56.55% | 5.35 33.45% | |
invested capital | 0.06 - | 0.15 126.37% | 0.19 27.48% | 0.23 25.77% | 0.03 86.92% | |||
market cap | 4.25B - | 4.25B 0% | 2.07B 51.30% | 7.76B 274.93% | 3.94B 49.24% | 1.09B 72.35% | 707.48M 35.02% | |
net current asset value | -381.86M - | -410.08M 7.39% | 271.43M 166.19% | 353.77M 30.34% | 83.51M 76.40% | 169.63M 103.13% | 57.33M 66.20% | |
net debt to ebitda | 2.31 - | 1.26 45.45% | 0.78 37.83% | 0.10 86.82% | 0.13 27.92% | -0.09 170.11% | -0.19 103.30% | |
net income per share | -0.41 - | -0.44 8.44% | -0.85 93.05% | -1.06 25.13% | -1.46 37.66% | -1.00 31.76% | -1.56 56.07% | |
operating cash flow per share | -0.33 - | -0.31 7.46% | 2.97 1,070.62% | -1.14 138.41% | -1.37 20.37% | -1.29 6.00% | 0.31 123.86% | |
payables turnover | 7.98 - | 10.97 37.40% | 5.00 54.40% | 6.96 39.15% | 14.91 114.19% | 7.16 51.95% | 10.01 39.71% | |
receivables turnover | 6.89 - | 11.58 68.12% | 6.71 42.04% | 9.79 45.91% | 8.87 9.46% | 4.63 47.82% | 4.48 3.06% | |
research and ddevelopement to revenue | 0.83 - | 0.70 15.47% | 0.83 18.15% | 1.18 41.95% | 0.92 21.83% | 0.76 17.05% | 0.72 6.25% | |
return on tangible assets | -0.19 - | -0.23 23.67% | -0.08 67.57% | -0.14 87.90% | -0.26 82.65% | -0.19 24.55% | -0.42 113.13% | |
revenue per share | 0.36 - | 0.53 44.77% | 1.23 132.97% | 0.75 39.04% | 1.10 46.67% | 1.30 18.24% | 1.18 9.30% | |
roe | 0.19 - | 0.18 5.63% | -0.10 157.24% | -0.19 82.39% | -0.34 81.20% | -0.31 9.84% | -0.73 138.06% | |
roic | 0.19 - | 0.21 6.29% | -0.10 150.52% | -0.15 45.86% | -0.25 64.61% | -0.21 16.46% | -0.50 136.62% | |
sales general and administrative to revenue | 0.41 - | 0.37 11.61% | 0.36 2.76% | 0.50 41.22% | 0.48 4.13% | 0.48 1.03% | ||
shareholders equity per share | -2.13 - | -2.45 14.91% | 8.26 437.25% | 5.66 31.39% | 4.30 24.03% | 3.26 24.32% | 2.14 34.44% | |
stock based compensation to revenue | 0.18 - | 0.20 9.87% | 0.15 22.98% | 0.25 63.14% | 0.28 11.34% | 0.30 6.83% | ||
tangible asset value | -358.91M - | -390.71M 8.86% | 440.14M 212.65% | 614.07M 39.52% | 476.60M 22.39% | 338.30M 29.02% | 189.31M 44.04% | |
tangible book value per share | -3.40 - | -3.71 8.86% | 6.36 271.72% | 4.68 26.46% | 3.40 27.44% | 2.37 30.10% | 1.31 44.77% | |
working capital | 184.24M - | 157.92M 14.29% | 534.38M 238.39% | 621.72M 16.34% | 288.94M 53.53% | 452.36M 56.56% | 322.17M 28.78% |
All numbers in (except ratios and percentages)